<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02918630</url>
  </required_header>
  <id_info>
    <org_study_id>HSC-MS-16-0667</org_study_id>
    <nct_id>NCT02918630</nct_id>
  </id_info>
  <brief_title>E-cigarettes to Promote Smoking Reduction Among Individuals With Schizophrenia</brief_title>
  <official_title>E-cigarettes to Promote Smoking Reduction Among Individuals With Schizophrenia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Texas Health Science Center, Houston</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The University of Texas Health Science Center, Houston</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess if access to an electronic nicotine delivery device,
      or e-cigarette, in addition to nicotine patch (21 mg) can help reduce cigarette smoking among
      individuals diagnosed with schizophrenia compared to nicotine patch alone.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2016</start_date>
  <completion_date type="Actual">August 2017</completion_date>
  <primary_completion_date type="Actual">August 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in smoking as assessed by breath Carbon Monoxide</measure>
    <time_frame>Baseline, Week 5</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Smoking as assessed by urinary cotinine</measure>
    <time_frame>Baseline, Week 5</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in smoking as assessed by a smoking diary</measure>
    <time_frame>Baseline, Week 5</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in smoking as assessed by timeline followback</measure>
    <time_frame>Baseline, Week 5</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in tobacco dependence as assessed by Fagerstrom Test for Nicotine Dependence (FTND)</measure>
    <time_frame>Baseline, Week 5</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in craving for tobacco cigarettes as assessed by the questionnaire of smoking urges (QSU)</measure>
    <time_frame>Baseline, Week 5</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in withdrawal systems from tobacco cigarettes as assessed by the Minnesota Nicotine Withdrawal Questionnaire (MNWQ)</measure>
    <time_frame>Baseline, Week 5</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in desire to quit tobacco cigarette smoking as assessed by stages of change questionnaire</measure>
    <time_frame>Baseline, Week 5</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Chronic Obstructive Pulmonary Disorder (COPD) related symptoms as assessed by the clinical COPD questionnaire</measure>
    <time_frame>Baseline, Week 5</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in confidence to quit tobacco smoking as assessed by the confidence to quit questionnaire</measure>
    <time_frame>Week 2, Week 5</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dependence on e-cigarettes as assessed by the e-cigarette dependence scale</measure>
    <time_frame>Week 5</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patterns of e-cigarette use as assessed by the E-cigarette patterns of use questionnaire</measure>
    <time_frame>Week 5</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satisfaction with e-cigarette as assessed by the e-cig evaluation</measure>
    <time_frame>Week 5</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>E-cigarette side effects as assessed by the E-cig side effects questionnaire</measure>
    <time_frame>Week 5</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in nicotine dependence as assessed by the hooked on nicotine questionnaire (HONQ)</measure>
    <time_frame>Baseline, Week 5</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in severity of schizophrenia symptoms as assessed by the brief psychiatric rating scale (BPRS)</measure>
    <time_frame>Baseline, Week 5</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in key cognitive domains associated with schizophrenia as assessed by the MATRICS Consensus Cognitive Battery (MCCB)</measure>
    <time_frame>Baseline, Week 5</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in positive symptoms of schizophrenia as assessed by the Scale for the Assessment of Positive Symptoms (SAPS)</measure>
    <time_frame>Baseline, Week 5</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in negative symptoms of schizophrenia as assessed by the Scale for the Assessment of Negative Symptoms (SANS)</measure>
    <time_frame>Baseline, Week 5</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in suicide ideation as assessed by the Columbia Suicide Severity Rating Scale (CSSRS)</measure>
    <time_frame>Baseline, Week 5</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">7</enrollment>
  <condition>Tobacco Smoking</condition>
  <arm_group>
    <arm_group_label>Nicotine Replacement Therapy - Nicotine Patch</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will receive nicotine patch (21 mg) starting study Week 1. Participants will be instructed to apply a new patch each morning.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nicotine Replacement Therapy + E-cigarette</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The e-cigarette will consist of 1) a 3.3 V, 1000 mAh battery; and 2) a 1.5 Ohm, dual-coil cartomizer (SmokTech; Shenzhen, China). Study staff will load the cartomizer with 1 ml tobacco flavored 70% propylene glycol/30% vegetable glycerin liquid containing nicotine concentrations 36 mg/ml (AVAIL; Richmond, Virginia, USA).</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nicotine Patch</intervention_name>
    <description>Participants will receive nicotine patch (21 mg) starting study Week 1. Participants will be instructed to apply a new patch each morning.</description>
    <arm_group_label>Nicotine Replacement Therapy - Nicotine Patch</arm_group_label>
    <arm_group_label>Nicotine Replacement Therapy + E-cigarette</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>E-cigarette</intervention_name>
    <description>The e-cigarette will consist of 1) a 3.3 V, 1000 mAh battery; and 2) a 1.5 Ohm, dual-coil cartomizer (SmokTech; Shenzhen, China). Study staff will load the cartomizer with 1 ml tobacco flavored 70% propylene glycol/30% vegetable glycerin liquid containing nicotine concentrations 36 mg/ml (AVAIL; Richmond, Virginia, USA).</description>
    <arm_group_label>Nicotine Replacement Therapy + E-cigarette</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Be diagnosed with schizophrenia

          -  Be in stable medical condition (DSM-V)

          -  report smoking ≥10 tobacco cigarettes/day

          -  present a breath CO ≥10 ppm

          -  report wanting to reduce their cigarette smoking

          -  be fluent in English

          -  have a stable living situation

        Exclusion Criteria:

          -  be currently pregnant or breastfeeding

          -  report wanting to quit smoking in the immediate future

          -  test positive for illicit drugs except THC

          -  have any illness, medical condition, or use of medications, which in the opinion of
             the study physicians would preclude safe and/or successful completion of the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jin Ho Yoon, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The University of Texas Health Science Center, Houston</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Texas Health Science Center at Houston</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77054</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 20, 2016</study_first_submitted>
  <study_first_submitted_qc>September 27, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 29, 2016</study_first_posted>
  <last_update_submitted>May 7, 2018</last_update_submitted>
  <last_update_submitted_qc>May 7, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 14, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The University of Texas Health Science Center, Houston</investigator_affiliation>
    <investigator_full_name>Jin Ho Yoon</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>E-cigarettes</keyword>
  <keyword>Schizophrenia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Schizophrenia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nicotine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

